What Does Abano Healthcare Group Limited's (NZSE:ABA) P/E Ratio Tell You?

By
Simply Wall St
Published
October 25, 2019
NZSE:ABA

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we'll show how Abano Healthcare Group Limited's (NZSE:ABA) P/E ratio could help you assess the value on offer. Abano Healthcare Group has a price to earnings ratio of 15.91, based on the last twelve months. That is equivalent to an earnings yield of about 6.3%.

View our latest analysis for Abano Healthcare Group

How Do You Calculate A P/E Ratio?

The formula for P/E is:

Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Or for Abano Healthcare Group:

P/E of 15.91 = NZ$4.65 ÷ NZ$0.29 (Based on the trailing twelve months to May 2019.)

Is A High P/E Ratio Good?

A higher P/E ratio means that buyers have to pay a higher price for each NZ$1 the company has earned over the last year. That isn't a good or a bad thing on its own, but a high P/E means that buyers have a higher opinion of the business's prospects, relative to stocks with a lower P/E.

Does Abano Healthcare Group Have A Relatively High Or Low P/E For Its Industry?

The P/E ratio indicates whether the market has higher or lower expectations of a company. As you can see below Abano Healthcare Group has a P/E ratio that is fairly close for the average for the healthcare industry, which is 15.9.

NZSE:ABA Price Estimation Relative to Market, October 25th 2019
NZSE:ABA Price Estimation Relative to Market, October 25th 2019

Abano Healthcare Group's P/E tells us that market participants think its prospects are roughly in line with its industry.

How Growth Rates Impact P/E Ratios

When earnings fall, the 'E' decreases, over time. That means even if the current P/E is low, it will increase over time if the share price stays flat. Then, a higher P/E might scare off shareholders, pushing the share price down.

Abano Healthcare Group saw earnings per share decrease by 30% last year. But over the longer term (5 years) earnings per share have increased by 38%. And over the longer term (3 years) earnings per share have decreased 40% annually. This might lead to low expectations. The market might expect further growth, but it isn't guaranteed. So investors should always consider the P/E ratio alongside other factors, such as whether company directors have been buying shares.

Don't Forget: The P/E Does Not Account For Debt or Bank Deposits

The 'Price' in P/E reflects the market capitalization of the company. That means it doesn't take debt or cash into account. The exact same company would hypothetically deserve a higher P/E ratio if it had a strong balance sheet, than if it had a weak one with lots of debt, because a cashed up company can spend on growth.

While growth expenditure doesn't always pay off, the point is that it is a good option to have; but one that the P/E ratio ignores.

So What Does Abano Healthcare Group's Balance Sheet Tell Us?

Abano Healthcare Group has net debt worth a very significant 117% of its market capitalization. If you want to compare its P/E ratio to other companies, you must keep in mind that these debt levels would usually warrant a relatively low P/E.

The Verdict On Abano Healthcare Group's P/E Ratio

Abano Healthcare Group has a P/E of 15.9. That's below the average in the NZ market, which is 19.0. When you consider that the company has significant debt, and didn't grow EPS last year, it isn't surprising that the market has muted expectations.

Investors have an opportunity when market expectations about a stock are wrong. If it is underestimating a company, investors can make money by buying and holding the shares until the market corrects itself. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with modest (or no) debt, trading on a P/E below 20.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

Promoted
If you decide to trade Abano Healthcare Group, use the lowest-cost* platform that is rated #1 Overall by Barron's, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.


Simply Wall St character - Warren

Simply Wall St

Simply Wall St is a financial technology startup focused on providing unbiased, high-quality research coverage on every listed company in the world. Our research team consists of equity analysts with a public, market-beating track record. Learn more about the team behind Simply Wall St.